Related Experiment Video

Updated: Jul 19, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Parental smoking increases exhaled nitric oxide in young children

P J Franklin1, S Turner, R Mutch

  • 1School of Paediatrics and Child Health, University of Western Australia, GPO Box D184, Perth 6840 Western Australia. peterf@sph.uwa.edu.au

The European Respiratory Journal
|October 3, 2006
PubMed

Insights

Children exposed to parental smoking show higher exhaled nitric oxide levels. This study found a dose-response relationship between parental smoking and fraction of exhaled nitric oxide (F(eNO)) in young children, indicating increased respiratory inflammation.

Area of Science:

  • Pediatric Pulmonology
  • Environmental Health
  • Biomarkers of Inflammation

Background:

  • Environmental tobacco smoke (ETS) exposure is a significant concern for child respiratory health.
  • Fraction of exhaled nitric oxide (F(eNO)) is a non-invasive marker of airway inflammation.
  • Previous research suggests links between ETS and adverse respiratory outcomes in children.

Purpose of the Study:

  • To investigate the association between parental smoking and F(eNO) levels in young children.
  • To determine if there is a dose-response relationship between the number of smoking parents and F(eNO).

Main Methods:

  • Recruited 78 young children (mean age 51.3 weeks).
  • Categorized children based on parental smoking status (none, one, or two smoking parents).
  • Measured F(eNO) using the modified single-breath technique.

Main Results:

  • Mean F(eNO) levels increased with the number of smoking parents (33.0 ppb for none, 38.3 ppb for one, 48.3 ppb for two).
  • A significant linear trend in F(eNO) levels across the parental smoking groups was observed.
  • A significant difference in F(eNO) between groups was found after controlling for confounding factors.

Conclusions:

  • Exposure to environmental tobacco smoke is associated with elevated F(eNO) in young children.
  • A dose-response relationship exists between parental smoking and F(eNO), suggesting increased airway inflammation with greater exposure.
  • Parental smoking is a significant factor contributing to respiratory inflammation markers in early childhood.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...